Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateGlucoTrack, Inc. Common Stock
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
Flagged at $1.03 at 10:12 AM on Oct 26, then ran to $1.76 +71% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is GCTK up today? It is at $1.47 (+82.29%), and our scanner flagged it 52 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GCTK spikes, and full due diligence on GCTK — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $GCTK 52 times in the last 30 days. Create a free account to track $GCTK, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
GCTK is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 18 unusual-volume and momentum alerts on GCTK today, peaking at 942.0x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystInc. Announces Reverse Stock SplitReverse split up to 1-for-2Status pending stockholder approval, from the latest SEC filing. Read it →* Institutional ownership was unavailable, so float is insider-deduped only.
Across every filing on file, supply equal to 77.8% of the tradeable float is in play - 77.8% more can still be issued.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
21,611,853 new shares (adjusted for the later reverse split)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in surgical & medical instruments & apparatus, closest in size first.
GCTK is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 18 unusual-volume and momentum alerts on GCTK today, peaking at 942.0x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
GCTK last traded at $1.47, up 82.29% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The GCTK Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GCTK 52 times in the last 30 days.
GCTK (GlucoTrack, Inc. Common Stock) trades on XNAS, with a market cap of about $2M in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GCTK for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$GCTK discussion
Sign in to ask a question or join the discussion.